NAVAMEDIC AS

Operating

Utvikle og markedsføre legemidler og andre produkter innen forbrukerhelse, utføre konsulenttjenester i denne sammenheng, og investere i relatert virksomhet.

Salg av farmasøytiske produkter, reseptfrie legemidler, reseptpliktige legemidler, kosttilskudd, medisinsk utstyr. Salg til grossist.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

Chairman of the board: LE
Lars Enghave Minor1970
Years since formation: 8 years; since Jun 9, 2018
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 740,101; 2 share classes
Total number of shareholders: 2; companies
Belongs to group of

Financials

Total operating income 2025: 201,809,824; NOK
Annual total result 2025: 34,735,640; NOK

Last update: Jul 29, 2026

Management

Board

Name	Role	Shares
LE Lars Enghave Minor 1970	Chairman	-
NO Nils Ole Krekling 1984	Board Member	-

Others

Name	Role	Shares
E ERNST & YOUNG AS	Auditor	-
S SOLIDITET AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
KE Kathrine Elisabeth Gamborg Andreassen 1966	-	2.79 % indirectly
AJ Astrid Johanne Torgersen Bratvedt 1963	-	2.17 % indirectly
OH Ole Henrik Eriksen 1959	-	2.08 % indirectly
EH Eline Huitfeldt 1954	-	1.81 % indirectly
WH Wold Hofstad Andreas 1995	-	1.29 % indirectly
LH Lars Hjarrand 1973	-	1.28 % indirectly
SM Shafi Mohammed Adan 1991	-	1.02 % indirectly
AA Arne Alexander Skøien Kvale 1991	-	1.02 % indirectly

Last update: Sep 8, 2026

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
N NAVAMEDIC ASA	A-shares	472,000	63.78 %
N NAVAMEDIC ASA	Class B shares	268,101	36.22 %

Last update: Jun 2, 2025

Group structure

NAVAMEDIC ASA
Total operating income 2025: NOK 67,348,341
Operating profit 2025: NOK -27,299,897
Employees: 21

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	201,809,824	201,580,044	215,623,616	200,504,688	0
Annual Total Result	34,735,640	38,452,920	42,223,406	60,574,991	-23,201
Total assets	0	197,089,416	234,361,614	200,043,537	135,462
Total liabilities	0	52,329,610	100,374,989	75,858,419	5,100
Total equity	0	144,759,806	133,986,625	124,185,117	130,362

P&L

Year	2025	2024	2023	2022	2021
Total operating income	201,809,824	201,580,044	215,623,616	200,504,688	0
Total operating costs	162,056,779	160,377,678	165,197,573	122,256,409	23,201
Operating result	39,753,045	41,202,366	50,426,043	78,248,279	-23,201
Financial income/costs	4,779,826	8,108,635	3,706,529	-737,984	0
Profit before tax	44,532,871	49,311,001	54,132,572	77,510,295	-23,201
Total tax & extraordinary income/cost	9,797,231	10,858,081	11,909,166	16,935,304	0
Annual Total Result	34,735,640	38,452,920	42,223,406	60,574,991	-23,201

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	100,584,786	0	0	0
Total current assets	96,504,631	234,361,614	200,043,537	135,462
Total assets	197,089,416	234,361,614	200,043,537	135,462
Short term debt	52,329,610	100,374,989	75,858,419	5,100
Long term debt	0	0	0	0
Total liabilities	52,329,610	100,374,989	75,858,419	5,100
Contributed capital	108,627,969	108,627,969	108,627,968	734,531
Retained earnings	36,131,837	25,358,656	15,557,149	-604,169
Total equity	144,759,806	133,986,625	124,185,117	130,362
Total equity and liabilities	197,089,416	234,361,614	200,043,537	135,462

Classification

21st company classification

BETA

Industrial large enterprise

NAVAMEDIC AS920 969 836

NAVAMEDIC AS

Keywords

Organization

Ownership

Financials

Management

Board

Others

Top 10 individual shareholders

Ownership

Company shareholders

Group structure

Financials

Summary

P&L

Balance overview

Classification